Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

NCT00453323 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Paclitaxel
DRUG: Capecitabine

Sponsor

National Cancer Center, Korea